📢 Exciting News! We’re thrilled to announce that @ActiveNeedle has been awarded the Horizon Pump Priming Funding Grant! ✨
A huge thank you to @UKRI_News and @innovateuk for this incredible opportunity!
Stay tuned for updates on our journey! 📣 ℹ️
#HorizonEurope#MedTech
Active Needle Technology Ltd. is proud to support #WorldCancerDay and its mission to #CloseTheCareGap.
Our innovative platform ultrasonic technology enables safe, effective #cancer diagnosis and treatment benefitting patients, clinicians and healthcare providers.
#medtech
Following a standout year of commercial success, we are excited to announce the opening of our new funding round with @Crowdcube .
For more details and to pre-register your non-binding interest, use the link below:
https://t.co/4NkM53tlag
#Medtech#Innovation#Ultrasound
📢 Exciting News! The voting results are in! 📊
We are thrilled to announce that @ActiveNeedle has made it into the finals of the Innovation Awards 2023 #IA2023 under the Technology Innovator of the Year category. @TechSupplyUK
We'd like to thank everyone who #voted for us!
@ActiveNeedle are proud to announce that we have been shortlisted for the Innovation Awards under the Tech Innovator of the Year category.
Please vote for us using the link below:
https://t.co/XIRNlvnRdV
Note: Voting closes at 6 pm on Friday 2nd June.
#TIAwards#medtech
@ActiveNeedle has successfully completed an @innovateUK#Edge grant funded project to focus on scaled manufacturing of ANT's devices.
Working with @the_MTC_org, the project helped us define methodologies to build devices at volume, and at a cost sufficient to satisfy market.
We are excited to announce that @ActiveNeedle has developed the world’s first #ultrasonic tattoo device, #Tranquill™, for medical and non-medical applications offering low-pain tattoo experience.
We'd like to thank @innovateuk for supporting the project.
#medtech#Wellbeing
We are excited to celebrate the International Day of Radiology today! #IDoR2022
We stand with, and support our colleagues for their continued hard work in the field of radiology.
#IDoR2022#ESR#radiology#radiologist#ultrasound
We are delighted to announce the grant of our first #patent in low pain ultrasonic needles. The technology opens a range of high value applications in #medical, #healthcare and #cosmetic markets.
We will continue to develop devices in these areas.
#Medtech#Innovation#Needle
We are developing a Precision Injection System to improve preclinical assessment of novel and re-purposed treatments prior to human use.
The operation and benefits of the system will be presented at an @NC3Rs webinar on Wednesday 12th October (14:00).
#CrackIT#technology
Discover how to:
✅ Improve preclinical injections in rodents
✅ Minimise loss of injectate
✅ Use new needles for each animal in minimal time
✅ Eliminate dead space to facilitate high-accuracy dosing
Webinar: Wednesday 12 October, 14.00 – 15.00 (BST). https://t.co/hL9poTX3Dr
@ActiveNeedle is delighted to welcome Woody YIP to the team!
Woody has joined the team as a Mechanical Design Engineer and will be working as part of the product development team on a number of exciting projects in both medical and non-medical sectors.
#team#medtech#design
@ActiveNeedle is delighted to welcome Kate Shenton to the team!
Kate will begin commercialisation of the company's novel, high accuracy drug delivery system, developed with scientists from @AstraZeneca, @GSK and @sheffielduni and supported by @NC3Rs.
#innovation#MEDTECH
@ActiveNeedle is honoured to have received additional funding from @NC3Rs to commercialise our new, high precision injection system.
More information can be found here:
https://t.co/lhR4sr5EGq
We are grateful to #NC3Rs and #MRC for their continued support.
#innovation
2/2 The grant will employ a subject-matter expert to detail the opportunity and buying-habits across key market sectors including #biotech, #pharma, and contract-research-organisations (#CROs).
We are grateful to @NC3Rs and @The_MRC for their continued support.
1/2 @ActiveNeedle is delighted to announce the award of an additional grant funding from @NC3Rs under their #BGS scheme to commercialise our new, high precision injection system developed with @AstraZeneca, @GSK and @sheffielduni.